Product Details

Veramph-C Suspension delivers Chloramphenicol for the treatment of serious bacterial infections in children. Specifically, each 5ml contains Chloramphenicol IP at 125mg, in a flavoured base. As a result, it offers potent broad-spectrum antibacterial coverage in a liquid formulation reserved for infections where other antibiotics are unsuitable or ineffective.

The suspension contains:

• Chloramphenicol IP (125mg per 5ml, in a flavoured base) – A broad-spectrum antibiotic that inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit. Consequently, it exerts bacteriostatic, and at higher concentrations bactericidal, activity against a wide range of gram-positive and gram-negative organisms, including many resistant strains.

Physicians prescribe Veramph-C for the treatment of serious bacterial infections such as typhoid fever and bacterial meningitis in children, particularly where first-line antibiotics have failed or are contraindicated. In addition, its flavoured oral suspension format supports administration in young patients under close medical supervision. Because of this profile, Veramph-C suits hospital and specialist paediatric settings managing serious bacterial infections that require careful monitoring during treatment.

Key Features:

• Overall, this formulation guarantees pharmaceutical-grade purity
• Additionally, the flavoured suspension format supports administration under medical supervision
• Furthermore, each 5ml delivers precise, validated dosage accuracy at 125mg
• Notably, rigorous quality testing backs every stage of manufacturing
• Beyond that, amber bottle packaging protects the light-sensitive formulation
• Ultimately, a reliable supply chain suits bulk distribution to hospitals and specialist clinics